CompanyDeals

Duality Biologics Licenses ADC Platform to Denmark’s Adcendo for Mesenchymal Tumor Program

Policy / Regulatory

NMPA Strengthens Oversight of COVID-19 Drugs and Home Treatment Guidelines

CompanyMedical Device

NMPA Approves Chinabridge’s ECMO Equipment for Emergency Use

CompanyDrug

EOC Pharma’s Entinostat NDA Accepted by China’s NMPA for Breast Cancer

CompanyDeals

HighTide Therapeutics Completes $107 Million Series C and C+ Financing Rounds

CompanyDeals

Biogen and Tsinghua University Launch Three-Year Neuroscience Collaboration

Policy / Regulatory

China’s NHC and NATCM Launch Integrated Pain Management Pilot Plan

CompanyDeals

Zhongchao Partners with Natco Pharma to Distribute Drugs in China

CompanyDeals

By-Health to Establish Nutrition Research Center with Shanghai Institute

CompanyDeals

CANbridge Secures Global Rights to Second-Generation Gene Therapy for SMA

CompanyDrug

Transcenta’s TST003 Receives Clinical Trial Approval in China and US

CompanyDrug

Henlius’ Hanbeitai Gains NMPA Approval for Expanded Indications